SALEM, N.H., Oct. 26, 2026 /PRNewswire/ -- Standex International Corporation (NYSE: SXI), a leading manufacturer of highly engineered components and systems, today announced that its Board of Directors has appointed Brenna D.

Brunswick's gross margin rebounded from 21.9% in 2024Q4 to 28.3% in 2026Q3, and revenue has resumed modest growth, suggesting the top-line recovery is real.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Gross margin recovered to 28.3% in 2026Q3 from 21.9% in 2024Q4, yet operating margin of 7.2% and trailing net margin of -2.6% show that SG&A at roughly 16% of revenue continues to absorb much of the gross profit gains.
Brunswick Corporation provides comprehensive quarterly and annual financial reports, including SEC filings like 10-Q and 10-K, ensuring transparency for investors.
The company publishes annual sustainability reports, highlighting its dedication to environmental and social governance, which can attract ESG-focused investors.
MarketBeat offers extensive SEC filing history and fundamental analysis for Brunswick Corporation, aiding investors in making informed decisions.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 29, 2026 | $1.58+17.0% vs $1.35 | $1.5B-0.1% vs $1.5B |
Q3 2026 Jul 30, 2026 | $1.56+31.1% vs $1.19 | $1.6B+2.3% vs $1.5B |
Q2 2026 Apr 30, 2026 | $0.70+52.2% vs $0.46 | $1.4B+4.2% vs $1.3B |
Q1 2026 Jan 29, 2026 | $0.58+0.0% vs $0.58 | $1.3B+10.1% vs $1.2B |
SALEM, N.H., Oct. 26, 2026 /PRNewswire/ -- Standex International Corporation (NYSE: SXI), a leading manufacturer of highly engineered components and systems, today announced that its Board of Directors has appointed Brenna D.

Hengrui Pharma Previews ESMO Congress 2026: 64 Research Findings Highlight Continued Progress Across Innovative Pipelines to Advance Clinical ValuePR NewswireSH
METTAWA, Ill., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Brunswick Corporation Declares Quarterly Dividend METTAWA, Ill.
VANCOUVER, British Columbia, Oct. 19, 2026 (GLOBE NEWSWIRE) -- A.I.S. Resources Limited (TSX-V: AIS ● OTC PINK: AISSF ● FRA: 5YH) (the “Company or “A.I.S) is pleased to announce its sponsorship of a Doctoral (PhD) research candidate to undertake advanced geological studies on the Company's St. John project in New Brunswick. The research initiative will be led by doctoral candidate Gilles Ngoran at the University of New Brunswick, under the academic supervision and mentorship of Dr. Kynan Hughson, Assistant Professor in the Department of Earth Sciences at the University.
Benchmark BC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Brunswick Corporation (BC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $77.23 | $5.02B | 23.82 | 2.4% | 3.69% | 12.95% | 2.22% | |
| $6.72 | $860.06M | -11.01 | 1.27% | -3.99% | -7.53% | — | |
| $20.22 | $397.06M | 48.27 | 13.25% | 0.86% | 1.6% | — | |
| $52.70 | $1.16B | -141.63 | -6.29% | -0.38% | -0.86% | — | |
| $20.36 | $331.46M | -247.69 | 22.77% | -0.48% | -0.7% | — | |
| $9.58 | $159.2M | -1.33 | 5.62% | -6.72% | -43.62% | 0.18% |
Brunswick Corporation (BC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Brunswick Corporation (BC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 29, 2026·SEC
Jul 30, 2026·SEC
Apr 30, 2026·SEC
Get notified when BC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Brunswick Corporation (BC) stock FAQ — growth, dividends, profitability & financials explained
Brunswick Corporation (BC) reported $5.72B in revenue over the trailing twelve months. Revenue was $5.36B in fiscal year 2025. That is 70% more than the $3.16B of fiscal year 1996.
Brunswick Corporation (BC) grew revenue by 10.4% over the trailing twelve months, compared with the twelve months before.
Yes. Brunswick Corporation (BC) earned $211.1M in net income over the trailing twelve months (a 3.7% net margin).
Yes. Brunswick Corporation (BC) pays a dividend that yields 2.22% at the current price, a moderate yield.
Brunswick Corporation (BC) had a return on equity (ROE) of 13.0% over the trailing twelve months. That is in line with the market's typical 10-15%.
Brunswick Corporation (BC) generated $372.9M in free cash flow over the trailing twelve months.